HealthMore in Health→
Medicare insulin cap cut costs, study finds, but gains were uneven
Key Takeaways
- A study of more than 2.8 million Medicare Part D beneficiaries found lower insulin costs after the $35 cap took effect.
- Patients with the highest prepolicy insulin costs showed the largest gains in fills and adherence.
- The average effect was limited because many Medicare beneficiaries were already partially protected by other programs.
DE
DT Editorial Team··via medicalxpress.com
